PCGEM1

Prostate-specific transcript 1 (non-protein coding), also known as PCGEM1, is a long non-coding RNA gene. In humans, it is located on chromosome 2q32. It is over-expressed in prostate cancer.[2][3] In a study of prostate tumours from 88 men, levels of PCGEM1 were found to be higher in prostate cancer cells in African-American men than in Caucasian-American men. The mortality rate of prostate cancer is highest in African-American men.[4]

PCGEM1
Identifiers
Aliases	PCGEM1, LINC00071, NCRNA00071, PCAT9, prostate-specific transcript (non-protein coding), prostate-specific transcript, PCGEM1 prostate-specific transcript
External IDs	OMIM: 605443 GeneCards: PCGEM1
Orthologs
Species	Human	Mouse
Entrez	64002	n/a
Ensembl	n/a	n/a
UniProt	n/a	n/a
RefSeq (mRNA)	n/a	n/a
RefSeq (protein)	n/a	n/a
Location (UCSC)	n/a	n/a
PubMed search	[1]	n/a
Wikidata
View/Edit Human

Prostate-specific transcript 1
Predicted secondary structure and sequence conservation of PCGEM1
Identifiers
Symbol	PCGEM1
Rfam	RF01981
Other data
RNA type	Gene;
Domain(s)	Eukaryota;
GO	0042981
SO	0001463
PDB structures	PDBe

PCGEM1 inhibits doxorubicin-induced apoptosis of cells, via delayed induction of p53 and p21.[5]

See also

• Long noncoding RNA
• Prostate cancer

References

1. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
2. Srikantan V, Zou Z, Petrovics G, et al. (October 2000). "PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer". Proc. Natl. Acad. Sci. U.S.A. 97 (22): 12216–12221. doi:10.1073/pnas.97.22.12216. PMC 17321. PMID 11050243.
3. Bialkowska-Hobrzanska H, Driman DK, Fletcher R, Harry V, Razvi H (February 2006). "Expression of human telomerase reverse transcriptase, Survivin, DD3 and PCGEM1 messenger RNA in archival prostate carcinoma tissue". Can J Urol. 13 (1): 2967–2974. PMID 16515751.
4. Petrovics G, Zhang W, Makarem M, et al. (January 2004). "Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients". Oncogene. 23 (2): 605–611. doi:10.1038/sj.onc.1207069. PMID 14724589.
5. Fu X, Ravindranath L, Tran N, Petrovics G, Srivastava S (March 2006). "Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1". DNA Cell Biol. 25 (3): 135–141. doi:10.1089/dna.2006.25.135. PMID 16569192.

Further reading

• Ifere GO, Barr E, Equan A, et al. (2009). "Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines". Cancer Detect. Prev. 32 (4): 319–328. doi:10.1016/j.cdp.2008.12.002. PMID 19186008.
• Enciso-Mora V, Hosking FJ, Houlston RS (2010). "Risk of breast and prostate cancer is not associated with increased homozygosity in outbred populations". Eur. J. Hum. Genet. 18 (8): 909–914. doi:10.1038/ejhg.2010.53. PMC 2987391. PMID 20407466.
• Romanuik TL, Wang G, Morozova O, Delaney A, Marra MA, Sadar MD (2010). "LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer". BMC Med. Genom. 3: 43. doi:10.1186/1755-8794-3-43. PMC 2956710. PMID 20868494.
• Ifere GO, Ananaba GA (November 2009). "Prostate cancer gene expression marker 1 (PCGEM1): a patented prostate- specific non-coding gene and regulator of prostate cancer progression". Recent Pat DNA Gene Seq. 3 (3): 151–163. PMID 19891595.

External links

• Page for Prostate-specific transcript 1 at Rfam